Cambridge Investment Research Advisors
ZOM

Cambridge Investment Research Advisors’s Zomedica Corp. ZOM Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-45,667
Closed -$5K – 3677
2024
Q4 		$5K Buy
45,667
+387
+0.9% +$49 ﹤0.01% 3455
2024
Q3 		$6K Hold
45,280
– – ﹤0.01% 3400
2024
Q2 		$7K Buy
45,280
+1,000
+2% +$150 ﹤0.01% 3302
2024
Q1 		$6K Sell
44,280
-78,000
-64% -$10.9K ﹤0.01% 3294
2023
Q4 		$24K Sell
122,280
-6,800
-5% -$1.2K ﹤0.01% 3136
2023
Q3 		$22K Sell
129,080
-11,128,480
-99% -$2.16M ﹤0.01% 3080
2023
Q2 		$2.25M Buy
11,257,560
+1,000
+0% +$203 0.01% 1102
2023
Q1 		$2.38M Buy
11,256,560
+64,400
+0.6% +$15.8K 0.01% 1036
2022
Q4 		$1.82M Hold
11,192,160
– – 0.01% 1129
2022
Q3 		$2.36M Buy
11,192,160
+20,000
+0.2% +$5.29K 0.01% 945
2022
Q2 		$2.46M Buy
11,172,160
+6,000
+0.1% +$1.53K 0.01% 949
2022
Q1 		$3.76M Buy
11,166,160
+23,500
+0.2% +$7.69K 0.02% 785
2021
Q4 		$3.42M Buy
11,142,660
+845
+0% +$381 0.02% 843
2021
Q3 		$5.83M Sell
11,141,815
-1,473
-0% -$869 0.03% 545
2021
Q2 		$9.28M Sell
11,143,288
-1,110,980
-9% -$1.04M 0.04% 390
2021
Q1 		$19.4M Buy
12,254,268
+188
+0% +$307 0.11% 202
2020
Q4 		$2.83M Hold
12,254,080
– – 0.02% 744
2020
Q3 		$1.35M Hold
12,254,080
– – 0.01% 1013
2020
Q2 		$2.92M Hold
12,254,080
– – 0.02% 623
2020
Q1 		$2.33M Buy
12,254,080
+181,000
+1% +$41.7K 0.02% 609
2019
Q4 		$4M Hold
12,073,080
– – 0.03% 547
2019
Q3 		$4.49M Hold
12,073,080
– – 0.04% 455
2019
Q2 		$2.78M Hold
12,073,080
– – 0.03% 596
2019
Q1 		$4.23M Hold
12,073,080
– – 0.04% 425
2018
Q4 		$14.8M Sell
12,073,080
-6,000
-0% -$9.51K 0.16% 131
2018
Q3 		$22.6M Hold
12,079,080
– – 0.22% 100
2018
Q2 		$27.2M Buy
12,079,080
+11,884,480
+6,107% +$23.9M 0.29% 71
2018
Q1 		$428K Hold
194,600
– – ﹤0.01% 1437
2017
Q4 		$385K Buy
+194,600
New +$432K ﹤0.01% 1472

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

Cambridge Investment Research Advisors's ZOM Position: Q1 2025 in Review

Cambridge Investment Research Advisors sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 45,667 shares — an estimated $5K sold.

Cambridge Investment Research Advisors first reported a position in ZOM in Q4 2017 and held it in 29 quarters. The position peaked at $27.2M in Q2 2018. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Cambridge Investment Research Advisors reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 45,667 Zomedica Corp. shares in Q1 2025, an estimated $5K.
  • Cambridge Investment Research Advisors first reported a position in Zomedica Corp. in Q4 2017 and held it in 29 quarters.
  • Cambridge Investment Research Advisors's Zomedica Corp. position peaked at $27.2M in Q2 2018.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.